NASDAQ:STTK

Shattuck Labs Stock Insider Trading

Healthcare > Biotechnology

Buy STTK

*Your capital is at risk

$5.39

+0.150 (+2.86%)

At Close: Jun 23, 2026

Shattuck Labs Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.22. In total, the insiders bought 192.76M and sold 6.21M STTK shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	99.22
● Buy	192.76M shares
● Sell	6.21M shares
87% Buy Activity Moderate Positive Correlation
Sell Signal Low Confidence May 12, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 99.22. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 11, 2026 Buy	Pre-Funded Warrants (right to buy) P-Purchase	Orbimed Advisors Llc Director	Director	1 041 667 Value: $104
Jun 11, 2026 Buy	Pre-Funded Warrants (right to buy) P-Purchase	Ashiya Mona Director	Director	208 333 Value: $21
Jun 11, 2026 Buy	Pre-Funded Warrants (right to buy) P-Purchase	Ashiya Mona Director	Director	1 041 667 Value: $104
Jun 11, 2026 Buy	Pre-Funded Warrants (right to buy) P-Purchase	Orbimed Advisors Llc Director	Director	208 333 Value: $21
Jun 09, 2026 Buy	Common Stock P-Purchase	Siegall Clay B Director	Director	62 500 Value: $250.0K
Jun 08, 2026 Sell	Common Warrants (right to buy) C-Conversion	Ashiya Mona Director	Director	3 073 298 Value: $3.33M
Jun 08, 2026 Buy	Pre-Funded Warrants (right to buy) C-Conversion	Ashiya Mona Director	Director	3 073 298 Value: $307
Jun 08, 2026 Buy	Pre-Funded Warrants (right to buy) C-Conversion	Orbimed Advisors Llc Director	Director	15 366 490 Value: $2K
Jun 08, 2026 Buy	Pre-Funded Warrants (right to buy) C-Conversion	Orbimed Advisors Llc Director	Director	3 073 298 Value: $307
Jun 08, 2026 Sell	Common Warrants (right to buy) C-Conversion	Orbimed Advisors Llc Director	Director	3 073 298 Value: $3.33M
Jun 08, 2026 Buy	Pre-Funded Warrants (right to buy) C-Conversion	Ashiya Mona Director	Director	15 366 490 Value: $2K
May 29, 2026 Buy	Stock Option (Right to Buy) A-Award	Baker Daniel G. Director	Director	81 000 Value: $482.0K
May 29, 2026 Buy	Stock Option (Right to Buy) A-Award	Golumbeski George Director	Director	81 000 Value: $482.0K
May 29, 2026 Buy	Stock Option (Right to Buy) A-Award	Gibson Neil W Director	Director	81 000 Value: $482.0K
May 29, 2026 Buy	Stock Option (Right to Buy) A-Award	Ashiya Mona Director	Director	81 000 Value: $482.0K
May 29, 2026 Buy	Stock Option (Right to Buy) A-Award	Siegall Clay B Director	Director	81 000 Value: $482.0K
May 29, 2026 Buy	Stock Option (Right to Buy) A-Award	Boudreau Helen M Director	Director	81 000 Value: $482.0K
May 22, 2026 Buy	Warrants (Right to Buy) M-Exempt	Siegall Clay B Director	Director	128 054 Value: $138.9K
May 22, 2026 Buy	Common Stock A-Award	Siegall Clay B Director	Director	128 054 Value: $138.9K
May 21, 2026 Buy	Warrants (Right to Buy) M-Exempt	Shukla Abhinav A. Chief Technical Officer	Officer	5 122 Value: $6K
May 21, 2026 Buy	Common Stock A-Award	Shukla Abhinav A. Chief Technical Officer	Officer	5 122 Value: $6K
May 15, 2026 Buy	Warrants (Right to Buy) M-Exempt	Stout Stephen See Remarks	Officer	12 805 Value: $13.9K
May 15, 2026 Buy	Common Stock A-Award	Stout Stephen See Remarks	Officer	12 805 Value: $13.9K
May 12, 2026 Sell	Common Stock S-Sale	Pandite Arundathy N. Chief Medical Officer	Officer	30 000 Value: $198.3K
May 12, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Shukla Abhinav A. Chief Technical Officer	Officer	2 032 Value: $7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT SHATTUCK LABS, INC.

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorpor...

Read Full Profile Here